CVE-2023-6078

OS Command Injection vulnerability affecting BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023

Description

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.25%
Vendor Advisory 3ds.com
Affected: Dassault Systèmes BIOVIA Materials Studio products
Published at:
Updated at:

References

Link Tags
https://www.3ds.com/vulnerability/advisories vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-6078?
CVE-2023-6078 has been scored as a high severity vulnerability.
How to fix CVE-2023-6078?
To fix CVE-2023-6078, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-6078 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-6078 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-6078?
CVE-2023-6078 affects Dassault Systèmes BIOVIA Materials Studio products.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.